Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nile Company for Pharmaceuticals and Chemical Industries is a prominent Egyptian pharmaceutical manufacturer and a subsidiary of the state-owned Holding Company for Pharmaceuticals (HoldiPharma). Founded in 1962, the company has established itself as a cornerstone of the Egyptian healthcare sector, producing a wide array of essential medicines. Its product portfolio encompasses over 200 formulations, including oral solids, liquid dosage forms, topicals, and sterile injectables. The company is particularly recognized for its production of insulin and treatments for chronic conditions such as cardiovascular and gastrointestinal diseases. Nile Pharma operates large-scale manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards, enabling it to serve both domestic and international markets. Beyond its own product lines, the company provides contract manufacturing services for several global pharmaceutical firms, leveraging its extensive industrial capacity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nile Company for Pharmaceuticals.